ZyVersa Therapeutics, Inc.
ZVSA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,413 | -$98,298 | -$14,048 | -$8,084 |
| Dep. & Amort. | $7 | $10 | $10 | $10 |
| Deferred Tax | $7 | -$9,479 | -$745 | -$442 |
| Stock-Based Comp. | $706 | $1,193 | $3,525 | $4,142 |
| Change in WC | $930 | $2,600 | $8,292 | -$1,020 |
| Other Non-Cash | $205 | $95,252 | -$1,922 | $318 |
| Operating Cash Flow | -$7,560 | -$8,721 | -$4,889 | -$5,076 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $5,230 |
| Stock Issued | $5,953 | $16,659 | $1,865 | $0 |
| Stock Repurch. | $0 | -$10,703 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$12,151 | $1,965 | $0 |
| Financing Cash Flow | $5,953 | $5,956 | $1,865 | $5,230 |
| Forex Effect | $0 | $0 | $8,597 | $0 |
| Net Chg. in Cash | -$1,607 | -$2,765 | $5,574 | $154 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,138 | $5,902 | $329 | $175 |
| End Cash | $1,531 | $3,138 | $699 | $329 |
| Free Cash Flow | -$7,560 | -$8,721 | -$1,495 | -$5,076 |